← All organizations

Imbioray (Hangzhou) Biomedicine Co., Ltd.

For profit

Also known as: Imbioray (Hangzhou) Biomedicine Co., Ltd.

Highest phase reached

Phase 2

First clinical trial

Nov 30, 2020

Last known activity

Aug 10, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (9 distinct, 7 trials)

Phase 2 (2 own, 0 via acquisition)

Recent trials (7)

Details

Last known activity
Aug 10, 2025